Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
7.770 USD  +0.210 (+2.78%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 Next >
Achillion Completes Phase 1a Trial of ACH-1625; Begins Dosing in Phase 1b Segment With HCV-Infected Patients
September 28, 2009
ACH-1625 Safe and Well-Tolerated in Single Ascending and Multiple Ascending Dose Trial Segments Read More
from GlobeNewswire News Releases
Achillion to Present At the Thomas Weisel Partners Annual Healthcare Conference
September 03, 2009
from GlobeNewswire News Releases
Achillion to Present At the Canaccord Adams 29th Annual Global Growth Conference
August 03, 2009
from GlobeNewswire News Releases
Achillion Reports Second Quarter and Six Month Financial Results
July 30, 2009
Conference Call to be Held Friday, July 31 At 8:00 a.m. ET Read More
from GlobeNewswire News Releases
Achillion Enters $15 Million Standby Equity Distribution Agreement
July 06, 2009
Provides Incremental Funding for HCV Pipeline Development Read More
from GlobeNewswire News Releases
Achillion Announces First-in-Human Dosing of ACH-1625 for Treatment of Hepatitis C
June 29, 2009
from GlobeNewswire News Releases
Achillion to Present At Upcoming Conferences
June 02, 2009
from GlobeNewswire News Releases
Achillion Reports First Quarter Financial Results and Provides Pipeline Update
May 15, 2009
from GlobeNewswire News Releases
Achillion Granted U.S. Patent for NS4A Antagonists in Hepatitis C
April 16, 2009
Receives Novel Mechanism of Action Claims as Inhibitor of Viral Replication Read More
from GlobeNewswire News Releases
Achillion to Present At the Canaccord Adams Hepatitis C Conference
April 03, 2009
from GlobeNewswire News Releases
Achillion Reports 2008 Fourth Quarter and Year-End Financial Results
March 25, 2009
from GlobeNewswire News Releases
Webcast Alert: Lippert/Heilshorn Life Sciences Conference Presentation (Achillion Pharmaceuticals, Inc.)
March 23, 2009
from Business Wire News Releases
Achillion to Present At the Cowen & Company 29th Annual Healthcare Conference
March 11, 2009
from GlobeNewswire News Releases
Achillion to Present At the 11th Annual BIO CEO & Investor Conference
February 05, 2009
from GlobeNewswire News Releases
Achillion Announces Appointment of New Head of Business Development
January 07, 2009
from GlobeNewswire News Releases
Achillion Appoints Dr. Dennis Liotta to Board of Directors
December 18, 2008
Emory University Professor is Renowned Developer of HIV Drugs Read More
from GlobeNewswire News Releases
Achillion to Present At Lazard Capital Markets 5th Annual Healthcare Conference
November 17, 2008
from GlobeNewswire News Releases
Achillion Reports Third Quarter 2008 Financial Results
October 28, 2008
from GlobeNewswire News Releases
Data From Achillion's Antibacterial and HIV Programs Presented At the 2008 ICAAC/IDSA Joint Meeting
October 27, 2008
from GlobeNewswire News Releases
Achillion Appoints Nicholas Simon to Board of Directors
August 20, 2008
from GlobeNewswire News Releases
Achillion Reports Second Quarter 2008 Financial Results
August 12, 2008
Conference Call Today At 4:30PM ET Read More
from GlobeNewswire News Releases
Achillion to Present At Canaccord Adams Global Growth Conference
August 12, 2008
from GlobeNewswire News Releases
Achillion Announces Private Placement Financing for up to $41.5 Million
August 06, 2008
from GlobeNewswire News Releases
Achillion Announces Additional Positive Top-Line Phase 2 Data for Elvucitabine
June 09, 2008
Data At 48 Weeks Build Upon Previously Reported Antiviral Activity and Safety Profile Read More
from GlobeNewswire News Releases
Achillion Nominates ACH-1625 as Lead Candidate in Proprietary Program Targeting HCV Protease
June 04, 2008
Candidate Demonstrates Promising In Vivo Safety Profile and Potent In Vitro Activity Against Hepatitis C Read More
from GlobeNewswire News Releases
Achillion to Present At Needham Biotechnology Conference
May 23, 2008
from GlobeNewswire News Releases
Achillion Reports First Quarter 2008 Financial Results
May 07, 2008
from GlobeNewswire News Releases
Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds
April 08, 2008
from GlobeNewswire News Releases
Achillion Appoints Gary E. Frashier to Board of Directors
April 02, 2008
from GlobeNewswire News Releases
Achillion to Present At Cowen Healthcare Conference
March 14, 2008
from GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here